Open AccessImproved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV Clinics
Author(s) -
P. Todd Korthuis,
Mary Jo Tozzi,
Vijay Nandi,
David A. Fiellin,
Linda Weiss,
James E. Egan,
Michael Botsko,
Ángela Acosta,
Marc N. Gourevitch,
David Hersh,
Jeffrey H. Hsu,
Joshua Boverman,
Frederick L. Altice
Publication year - 2011
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e318209754c
Subject(s) - buprenorphine , medicine , opioid , human immunodeficiency virus (hiv) , quality of life (healthcare) , opiate substitution treatment , narcotic antagonists , opioid related disorders , virology , opioid epidemic , (+) naloxone , nursing , receptor
Opioid dependence and HIV infection are associated with poor health-related quality of life (HRQOL). Buprenorphine/naloxone (bup/nx) provided in HIV care settings may improve HRQOL.